Replacing Traditional Hydrophilic–Lipophilic Balance Systems with a First-in-Class Tri-Domain Delivery Platform: NanoBase™

Skincare innovation has been constrained for decades by Hydrophilic–Lipophilic Balance (HLB) emulsification logic, a framework created to solve jar stability, not controlled deposition, distribution uniformity, or functional bioavailability on living skin. This manuscript introduces NanoBase™ as a first-in-class tri-domain delivery architecture engineered to replace single-interface HLB systems with a deposition-focused formulation baseline. NanoBase™ integrates nanoemulsion, nanoliposomal, and nanomicellar domains within a coordinated lipid-based matrix, addressing structural limitations commonly observed in legacy emulsions, including uneven surface loading, payload drift over shelf life, hotspot-driven irritation, and inconsistent outcomes across skin types. Grounded in peer-reviewed lipid carrier science, the paper reframes “ingredient performance” as an architectural question, then proposes a practical validation model using established methods such as tape stripping, Franz diffusion testing, and confocal Raman spectroscopy. Rather than presenting delivery as an optional enhancement, this document argues for an updated formulation paradigm, where the delivery chassis itself becomes the primary determinant of repeatable, measurable performance.